Status:
UNKNOWN
The Effect of iv Ondansetron on Reducing Hypotension Due to BCIS in Total Knee Prosthesis Surgery
Lead Sponsor:
Ataturk University
Conditions:
Bone Cement Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Bone cement implantation syndrome (BCIS) is a complication associated with the implantation of polymethylmethacrylate bone cement. Hypoxia, hypotension, and/or unexpected loss of consciousness often r...
Detailed Description
THE EFFECT OF INTRAVENOUS ONDANSETRON ON REDUCING HYPOTENSION DUE TO BONE CEMENT SYNDROME IN TOTAL KNEE PROSTHESIS SURGERY: A RANDOMIZED CONTROLLED THREE-BLIND STUDY Bone cement implantation syndrome...
Eligibility Criteria
Inclusion
- Unilateral TDA
- ASA I-III physical condition
- patients aged ≥18 years,
Exclusion
- Patients with classical contraindications to subarachnoidal block,
- morbidly obese (body mass index \> 35 kg / m2),
- hypersensitive to ondansetron and allergic to local anesthetic agents,
- taking selective serotonin reuptake inhibitors or serotonin-related migraine drugs,
- unstable angına,
- patients with hemodynamically severe aortic-mitral valve stenosis,
- severe carotid artery stenosis and severe pulmonary, renal, hepatic, cerebrovascular or psychiatric disease,
- neurological or cerebrovascular disease or psychiatric disease,
- hypertension but unable to take medication or arterial hypertension uncontrolled with oral medications,
- ASA\>III physical condition,
- patients with preoperative anemia
- patients who do not want to participate in the study will be excluded from the study
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT05405608
Start Date
June 1 2022
End Date
September 1 2022
Last Update
June 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aysenur Dostbil
Yakutiye, Erzurum, Turkey (Türkiye), 25000